Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Why do cholestatic patients itch?

Literature DB >> 8707105

Why do cholestatic patients itch?

E A Jones¹, N V Bergasa.

Abstract

Entities: Disease Species

Mesh：

Substances：
Narcotic Antagonists

Year: 1996 PMID： 8707105 PMCID： PMC1383141 DOI： 10.1136/gut.38.5.644

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

16 in total

1. Relief of intractable pruritus with naloxone.

Authors: J E Bernstein; R Swift
Journal: Arch Dermatol Date: 1979-11

2. The medullary dorsal horn: a target for the expression of opiate effects on the perceived intensity of noxious heat.

Authors: J L Oliveras; W Maixner; R Dubner; M C Bushnell; D R Kenshalo; G H Duncan; D A Thomas; R Bates
Journal: J Neurosci Date: 1986-10 Impact factor: 6.167

3. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron.

Authors: Harald Schwörer; Heinz Hartmann; Giuliano Ramadori
Journal: Pain Date: 1995-04 Impact factor: 6.961

4. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial.

Authors: N V Bergasa; D W Alling; T L Talbot; M G Swain; C Yurdaydin; M L Turner; J M Schmitt; E C Walker; E A Jones
Journal: Ann Intern Med Date: 1995-08-01 Impact factor: 25.391

5. Cholestasis in the male rat is associated with naloxone-reversible antinociception.

Authors: N V Bergasa; D W Alling; J Vergalla; E A Jones
Journal: J Hepatol Date: 1994-01 Impact factor: 25.083

6. Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists.

Authors: H Schwörer; G Ramadori
Journal: Clin Investig Date: 1993-08

Review 7. [Cholestatic pruritus--pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists].

Authors: H Schwörer; G Ramadori
Journal: Z Gastroenterol Date: 1995-05 Impact factor: 2.000

Why do cholestatic patients itch?

1. Relief of intractable pruritus with naloxone.

2. The medullary dorsal horn: a target for the expression of opiate effects on the perceived intensity of noxious heat.

3. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron.

4. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial.

5. Cholestasis in the male rat is associated with naloxone-reversible antinociception.

6. Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists.

Review 7. [Cholestatic pruritus--pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists].

8. Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys.

9. Opioid peptides and primary biliary cirrhosis.

10. Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver.

1. Molecular Adsorbents Recirculating System dialysis in children with cholestatic pruritus.

2. Association between Itch and Cancer in 3836 Pediatric Pruritus Patients at a Tertiary Care Center.